MarketCap
PDS Biotechnology Corporation PDSB
$ 1.02
-5.56%
Facebook
X
Telegram
Country |
 USA |
IPO year |
2015 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
46.4 M |
Market Cap[1] |
$ 47.3 M |
EBITDA (LTM) |
$ -31.5 M |
P/E (LTM) |
-0.297297 |
P/S (LTM) |
- |
EPS (LTM) |
-0.74 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
TFF Pharmaceuticals
TFFP
|
- | -60.05 % | $ 125 K | Nasdaq Global Select Market | USA |
 |
Mesoblast Limited
MESO
|
$ 14.0 | -3.06 % | $ 16.9 B | Nasdaq Global Select Market |  Australia |
 |
CorMedix
CRMD
|
$ 5.37 | -2.1 % | $ 387 K | Nasdaq Global Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market |  Britain |
 |
MannKind Corporation
MNKD
|
$ 4.22 | 0.84 % | $ 1.29 B | Nasdaq Global Market | USA |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
MediciNova
MNOV
|
$ 1.4 | -4.76 % | $ 68.7 M | Nasdaq Global Market | USA |
 |
Merck & Co.
MRK
|
$ 147.75 | -0.68 % | $ 370 B | NYSE,SPB | USA |
 |
Moderna
MRNA
|
$ 250.79 | -6.77 % | $ 97.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Axcella Health
AXLA
|
- | -16.42 % | $ 249 M | Nasdaq Global Market | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Intellia Therapeutics
NTLA
|
$ 11.18 | -7.72 % | $ 1.21 B | Nasdaq Global Market,SPB | USA |
 |
Novartis AG
NVS
|
$ 163.39 | -0.18 % | $ 317 B | NYSE |  Schweiz |
 |
Omeros Corporation
OMER
|
$ 17.3 | -1.48 % | $ 1.1 B | Nasdaq Global Select Market | USA |
 |
Oramed Pharmaceuticals
ORMP
|
$ 3.97 | -0.75 % | $ 164 M | Nasdaq Global Select Market |  Israel |
 |
Tyme Technologies
TYME
|
- | 8.07 % | $ 54 M | Nasdaq Capital Market | USA |
 |
Puma Biotechnology
PBYI
|
$ 8.13 | -3.22 % | $ 407 M | Nasdaq Global Select Market | USA |
 |
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Pfizer
PFE
|
$ 29.34 | 0.36 % | $ 167 B | NYSE,SPB | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB |  Russia |
 |
PainReform Ltd.
PRFX
|
$ 0.78 | -4.24 % | $ 505 K | Nasdaq Capital Market | Israel |
 |
Prothena Corporation plc
PRTA
|
$ 8.56 | -2.51 % | $ 461 M | Nasdaq Global Select Market,SPB | USA |
 |
Arcus Biosciences
RCUS
|
$ 18.66 | -1.56 % | $ 2 B | NYSE,SPB | USA |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
$ 14.9 | -1.03 % | $ 12.4 B | NYSE |  India |
 |
Regeneron Pharmaceuticals
REGN
|
$ 916.16 | -0.41 % | $ 95.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Replimune Group
REPL
|
$ 23.3 | 4.67 % | $ 2.16 B | Nasdaq Global Select Market | USA |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
Royalty Pharma plc
RPRX
|
$ 69.47 | 1.02 % | $ 29.9 B | Nasdaq Global Select Market | USA |
 |
Revolution Medicines
RVMD
|
$ 193.0 | -3.57 % | $ 36.7 B | Nasdaq Global Select Market | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 113.99 | 0.04 % | $ 7.41 B | Nasdaq Global Market,SPB | USA |
 |
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | USA |
 |
Sana Biotechnology
SANA
|
$ 2.43 | -1.42 % | $ 615 M | Nasdaq Global Select Market | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 61.81 | 0.11 % | $ 172 M | Nasdaq Global Select Market | Israel |
 |
Summit Therapeutics
SMMT
|
$ 17.78 | -0.34 % | $ 13.3 B | Nasdaq Global Select Market | Britain |
 |
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | USA |
 |
Syndax Pharmaceuticals
SNDX
|
$ 9.43 | -0.89 % | $ 817 M | Nasdaq Global Select Market | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.01 | -5.61 % | $ 56.6 M | Nasdaq Global Select Market | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 16.4 | -5.54 % | $ 1.64 B | Nasdaq Global Select Market,SPB | USA |
 |
Tarsus Pharmaceuticals
TARS
|
$ 73.9 | 4.32 % | $ 3.09 B | Nasdaq Global Select Market | USA |
 |
Bio-Techne Corporation
TECH
|
$ 72.83 | -0.01 % | $ 11.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE | Israel |
 |
Cabaletta Bio
CABA
|
$ 1.43 | -5.0 % | $ 144 M | Nasdaq Global Select Market | USA |
 |
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market |  Irlanda |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 4.12 | -8.35 % | $ 35.1 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.